All KLOW certificates

KLOW 80 mg Certificate of Analysis Batch APL-KLOW80-2606-01

KLOW 80 mg from batch APL-KLOW80-2606-01 was analysed on 17 June 2026 and measured 99.18% combined purity across GHK-Cu, KPV, TB-500 and BPC-157 by HPLC / Mass Spectrometry, passing all 5 release tests.

Combined purity
99.18%
Components
GHK-Cu, KPV, TB-500, BPC-157
Result
All 5 tests passed
Tested
17 June 2026
Method
HPLC / Mass Spectrometry
Net content
80.45 mg

Independent verification

KLOW 80 mg is independently verified by Ozcanium Analytics, an independent Australian laboratory, at 99.40% purity by UPLC-MS/MS, analysed 27 August 2026 on lot APL-KLOW80-2608-01, net content GHK-Cu 51.38 mg, KPV 10.58 mg, BPC-157 10.44 mg, TB-500 10.58 mg, verification code OZ-HPLCMS-BJ29.

Issued by Ozcanium Analytics. Covers every vial size of this compound; each report opens as the laboratory issued it.

Enter a code in the Ozcanium Analytics verification portal (opens in a new tab) to confirm the report against their own records.

The certificate as issued is reproduced below — pinch to zoom on a phone, or use Print / Save as PDF for a full-size copy.

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 1 of 5

Certificate of Analysis KLOW 80 mg Batch APL-KLOW80-2606-01
Compound Mix
KLOW
Lot Number
APL-KLOW80-2606-01
Analysis Date
17 June 2026
Method
HPLC / Mass Spectrometry
Purity
99.18%
Net Content
80.45 mg
KLOW vial
Net Content
  • GHK-Cu50.24 mg
  • KPV10.06 mg
  • TB-50010.11 mg
  • BPC-15710.04 mg
Form
Lyophilised Powder
Manufactured
June 2026
Issued
18 June 2026
Document ID
APL-COA-KLOW80-2606-01
Verification Code
Batch traceable

High Performance Liquid Chromatography (HPLC-UV) Chromatogram

mAUPDA 214 nm01883755637500123456 min 1.3361.536GHK-Cu1.916KPV2.2062.996TB-5003.286BPC-1573.7965.146

4 components resolved on a single gradient and assigned by retention time against individually run reference standards. Purity is reported as their combined peak area; the remaining 4 integrated peaks are unassigned process impurities. Component share of total peak area reflects UV response at 214 nm, not the mass ratio in the vial.

Peak List

Peaks detected: 8
#Time (min)Area% AreaAssignment
11.33616,4160.190—
21.5363,988,54846.164GHK-Cu
31.9161,968,93922.789KPV
42.20622,4640.260—
52.996969,78911.224TB-500
63.2861,641,87619.003BPC-157
73.79620,7360.240—
85.14611,2320.130—

Analytical Results

TestSpecificationResultStatus
AppearanceBlue/Blue-Green Lyophilised PowderConformsPASS
Identity (MS)All components confirmedConfirmedPASS
Purity (HPLC)≥98.0% combined99.18%PASS
Total Peptide Content95–105%99.2%PASS
Endotoxins<0.5 EU/mg<0.25 EU/mgPASS

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 2 of 5

GHK-Cu

PubChem CID: 133697840 · CAS Number: 49557-75-7

Formula: C14H24CuN6O4 · MW: 403.92 g/mol · In this vial: 50.24 mg

SequenceGly-His-Lys

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 17 June 2026
Monitored (m/z)Detected (m/z)Relative Intensity
405404.91.29
427426.892.36

Detection assignment: GHK-Cu

Collected Mass Spectrum

Intensity ×107

0123100200300400500600700800 m/z 405427

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 3 of 5

KPV

PubChem CID: 125672 · CAS Number: 67727-97-3

Formula: C16H30N4O4 · MW: 342.4 g/mol · In this vial: 10.06 mg

SequenceLys-Pro-Val

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 17 June 2026
Monitored (m/z)Detected (m/z)Relative Intensity
343343.391.37
365365.360.82

Detection assignment: KPV

Collected Mass Spectrum

Intensity ×107

00.511.50100200300400500600700 m/z 343365

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 4 of 5

TB-500

PubChem CID: 16132341 · CAS Number: 77591-33-4

Formula: C212H350N56O78S · MW: 4963.4 g/mol · In this vial: 10.11 mg

SequenceAc-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES (43 aa, N-terminally acetylated)

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 17 June 2026
Monitored (m/z)Detected (m/z)Relative Intensity
828828.250.63
994993.661.46
12421241.870.95

Detection assignment: TB-500

Collected Mass Spectrum

Intensity ×107

00.511.52500700900110013001500 m/z 8289941242

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 5 of 5

BPC-157

PubChem CID: 9941957 · CAS Number: 137525-51-0

Formula: C62H98N16O22 · MW: 1419.5 g/mol · In this vial: 10.04 mg

SequenceGEPPPGKPADDAGLV

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 17 June 2026
Monitored (m/z)Detected (m/z)Relative Intensity
474474.20.57
711710.751.18
14211420.50.41

Detection assignment: BPC-157

Collected Mass Spectrum

Intensity ×107

00.511.5020040060080010001200140016001800 m/z 4747111421

Verification Protocol

  • Identity confirmed separately for each component by mass spectrometry against its own expected ion channels.
  • Purity measured by HPLC as the combined area of every assigned component peak against all integrated impurity peaks.
  • Batch traceability: this document reports the lot number printed on the vial.
  • Analysis performed in-house by Australian Peptide Labs.

Supplied for laboratory research use only. Not a therapeutic good; not for human or veterinary use.

View KLOW in the catalogueHow to read this certificate